[NUVA] NuVasive, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 66.29 Change: 0.51 (0.78%)
Ext. hours: Change: 0 (0%)

chart NUVA

Refresh chart

Strongest Trends Summary For NUVA

NUVA is in the long-term up 152% in 11 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company?s principal product offering includes a minimally disruptive surgical platform, known Maximum Access Surgery (MAS) that includes its proprietary software-driven nerve detection and avoidance systems, NVM5 and NVJJB, and intra-operative monitoring (IOM) support; MaXcess, an integrated split-blade retractor system; and various specialized implants. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company?s biologic product line offerings used to aid the spinal fusion process or bone healing consist of allograft (donated human tissue); Osteocel Plus, an allograft cellular matrix containing via

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 6.84% Sales Growth - Q/Q5.47% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA3.69% ROE7.11% ROI4.18%
Current Ratio5.17 Quick Ratio3.93 Long Term Debt/Equity0.67 Debt Ratio0.2
Gross Margin76.15% Operating Margin15.49% Net Profit Margin6.01% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-26.25 M Cash From Investing Activities-72.14 M Cash From Operating Activities35.18 M Gross Profit154.5 M
Net Profit10.27 M Operating Profit25.86 M Total Assets1.29 B Total Current Assets684.33 M
Total Current Liabilities132.44 M Total Debt368.5 M Total Liabilities618.32 M Total Revenue202.91 M
Technical Data
High 52 week71.41 Low 52 week44.53 Last close60.98 Last change-1.6%
RSI52.12 Average true range1.98 Beta1 Volume185.56 K
Simple moving average 20 days0.26% Simple moving average 50 days5% Simple moving average 200 days2.38%
Performance Data
Performance Week-1.45% Performance Month13.18% Performance Quart4.08% Performance Half5.52%
Performance Year22.16% Performance Year-to-date23.04% Volatility daily1.92% Volatility weekly4.3%
Volatility monthly8.81% Volatility yearly30.52% Relative Volume231.69% Average Volume588.92 K
New High New Low

News

2019-06-18 10:22:02 | NuVasive Grows on Strong Product Adoption Amid Pricing Woe

2019-06-18 07:27:11 | NuVasive Launches Titanium Spine Implant Modulus TLIF-O

2019-06-17 08:30:00 | NuVasive Expands Advanced Materials Science™ Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion

2019-06-12 08:30:00 | NuVasive LessRay® Platform Wins Gold at 2019 Medical Design Excellence Awards

2019-06-10 08:06:13 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-05-31 09:31:01 | Why Is NuVasive NUVA Down 3.9% Since Last Earnings Report?

2019-05-30 08:30:00 | NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System

2019-05-30 08:06:06 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-05-29 09:47:51 | Is NuVasive, Inc. NASDAQ:NUVA A Financially Sound Company?

2019-05-28 08:55:12 | Here's Why You Should Retain NuVasive NUVA Stock for Now

2019-05-28 08:06:18 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-05-21 09:28:01 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-05-14 09:30:01 | VREX vs. NUVA: Which Stock Is the Better Value Option?

2019-05-14 08:30:00 | NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting

2019-05-07 08:06:28 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-05-06 16:05:00 | NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019

2019-05-06 08:20:01 | How NuVasive, Inc. NASDAQ:NUVA Can Impact Your Portfolio Volatility

2019-05-02 12:00:09 | Edited Transcript of NUVA earnings conference call or presentation 1-May-19 8:30pm GMT

2019-05-02 11:37:03 | NuVasive NUVA Q1 Earnings Top Estimates, Margins Strong

2019-05-02 05:35:09 | NuVasive Inc NUVA Q1 2019 Earnings Call Transcript

2019-05-01 20:05:00 | NuVasive Straightens Up to Start 2019

2019-05-01 18:05:10 | NuVasive NUVA Q1 Earnings and Revenues Top Estimates

2019-05-01 16:55:37 | NuVasive: 1Q Earnings Snapshot

2019-05-01 16:02:00 | NuVasive Announces First Quarter 2019 Financial Results

2019-05-01 11:53:26 | A Preview Of NuVasive's Q1 Earnings

2019-04-30 08:06:23 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-04-29 09:45:56 | Is NuVasive, Inc. NUVA A Good Stock To Buy?

2019-04-24 10:33:02 | NuVasive NUVA Reports Next Week: Wall Street Expects Earnings Growth

2019-04-22 08:30:00 | Clinical Study Demonstrates NuVasive Cohere® Porous PEEK™ Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK

2019-04-15 16:05:00 | NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results

2019-04-11 05:30:00 | Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360™ System At AANS 2019

2019-04-09 10:51:01 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-04-05 08:30:00 | NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards

2019-04-02 10:50:02 | NuVasive NUVA Completes First COHERE XLIF Case in U.S.

2019-04-01 08:30:00 | NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases

2019-03-22 09:30:01 | NuVasive NUVA Down 1% Since Last Earnings Report: Can It Rebound?

2019-03-12 15:30:51 | Options Bears Jump on Battered NuVasive Stock

2019-03-12 10:31:46 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-03-06 16:05:00 | NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At Spine Summit 2019

2019-03-06 13:39:00 | Why NuVasive Stock Rose 18% in February

2019-03-06 07:55:00 | Research Report Identifies E*TRADE Financial, Kennedy-Wilson, Alteryx, PTC Therapeutics, Ocean Power Technologies, and NuVasive with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2019-03-05 16:05:00 | NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference

2019-02-22 07:50:12 | NuVasive NUVA Q4 Earnings Beat Estimates, Margins Fall

2019-02-21 16:05:00 | NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference

2019-02-21 14:17:47 | NuVasive NUVA Q4 2018 Earnings Conference Call Transcript

2019-02-21 05:58:03 | Edited Transcript of NUVA earnings conference call or presentation 20-Feb-19 9:30pm GMT

2019-02-20 18:21:00 | NuVasive Overcomes Industry Headwinds to Finish 2018 Strong

2019-02-20 17:40:10 | NuVasive NUVA Q4 Earnings and Revenues Top Estimates

2019-02-20 16:34:26 | NuVasive: 4Q Earnings Snapshot

2019-02-20 16:02:00 | NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results